» Articles » PMID: 38501132

Investigating the Role of CFTR in Human and Mouse Myometrium

Overview
Date 2024 Mar 19
PMID 38501132
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Abnormal cystic fibrosis transmembrane conductance regulator (CFTR) function in cystic fibrosis (CF) has been linked to airway smooth muscle abnormalities including bronchial hyperresponsiveness. However, a role for CFTR in other types of smooth muscle, including myometrium, remains largely unexplored. As CF life expectancy and the number of pregnancies increases, there is a need for an understanding of the potential role of CFTR in myometrial function.

Methods: We investigated the role of CFTR in human and mouse myometrium. We used immunofluorescence to identify CFTR expression, and carried out contractility studies on spontaneously contracting term pregnant and non-pregnant mouse myometrium and term pregnant human myometrial biopsies from caesarean sections.

Results: CFTR was found to be expressed in term pregnant mouse myometrium. Inhibition of CFTR, with the selective inhibitor CFTR-172, significantly reduced contractility in pregnant mouse and human myometrium in a concentration-dependent manner (44.89 ± 11.02 term pregnant mouse, 9.23 ± 4.75 term-pregnant human; maximal effect at 60 μM expressed as a percentage of the pre-treatment control period). However, there was no effect of CFTR-172 in non-pregnant myometrium.

Conclusion: These results demonstrate decreased myometrial function when CFTR is inhibited, which may have implications on pregnancy and labour outcome and therapeutic decisions for labour in CF patients.

References
1.
Song J, Zhang X, Qi Z, Sun G, Chi S, Zhu Z . Cloning and characterization of a calcium-activated chloride channel in rat uterus. Biol Reprod. 2009; 80(4):788-94. DOI: 10.1095/biolreprod.108.071258. View

2.
Jin H, Wen G, Deng S, Wan S, Xu J, Liu X . Oestrogen upregulates the expression levels and functional activities of duodenal mucosal CFTR and SLC26A6. Exp Physiol. 2016; 101(11):1371-1382. DOI: 10.1113/EP085803. View

3.
Elborn J . Cystic fibrosis. Lancet. 2016; 388(10059):2519-2531. DOI: 10.1016/S0140-6736(16)00576-6. View

4.
Arrowsmith S, Neilson J, Bricker L, Wray S . Differing In Vitro Potencies of Tocolytics and Progesterone in Myometrium From Singleton and Twin Pregnancies. Reprod Sci. 2015; 23(1):98-111. DOI: 10.1177/1933719115597788. View

5.
Wiberg-Itzel E, Wray S, Akerud H . A randomized controlled trial of a new treatment for labor dystocia. J Matern Fetal Neonatal Med. 2017; 31(17):2237-2244. DOI: 10.1080/14767058.2017.1339268. View